Variant report
Variant | nsv823406 |
---|---|
Chromosome Location | chr6:5569236-5569941 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182751427 | chr6:5569258-5569259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558203347 | chr6:5569288-5569289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149576318 | chr6:5569305-5569306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534553226 | chr6:5569322-5569323 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552458659 | chr6:5569347-5569348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117371232 | chr6:5569349-5569350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377367341 | chr6:5569354-5569355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534006642 | chr6:5569393-5569394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368913885 | chr6:5569423-5569424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563680375 | chr6:5569442-5569443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35999608 | chr6:5569472-5569473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187484634 | chr6:5569532-5569533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9504437 | chr6:5569534-5569535 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs564449361 | chr6:5569572-5569573 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74923792 | chr6:5569581-5569582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113477851 | chr6:5569640-5569641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144310023 | chr6:5569643-5569644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148714547 | chr6:5569644-5569645 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs60484538 | chr6:5569668-5569669 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs183640983 | chr6:5569689-5569690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs386696514 | chr6:5569701-5569702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200258132 | chr6:5569703-5569704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575597736 | chr6:5569715-5569716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116819460 | chr6:5569738-5569739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570496320 | chr6:5569750-5569751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534716239 | chr6:5569771-5569772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529307835 | chr6:5569790-5569791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552896804 | chr6:5569802-5569803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574536652 | chr6:5569804-5569805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535763278 | chr6:5569829-5569830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557261467 | chr6:5569844-5569845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575585726 | chr6:5569906-5569907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:5538000-5573600 | Weak transcription | Left Ventricle | heart |
2 | chr6:5551600-5575200 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr6:5562800-5569800 | Weak transcription | Psoas Muscle | Psoas |
4 | chr6:5565200-5576600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:5565200-5583200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr6:5567000-5575200 | Weak transcription | Primary T cells from cord blood | blood |
7 | chr6:5567400-5572800 | Weak transcription | Primary B cells from peripheral blood | blood |
8 | chr6:5568600-5569800 | Weak transcription | HepG2 | liver |
9 | chr6:5568800-5570200 | Enhancers | Right Atrium | heart |
10 | chr6:5569000-5571200 | Enhancers | GM12878-XiMat | blood |
11 | chr6:5569600-5570000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr6:5569800-5570000 | Enhancers | Psoas Muscle | Psoas |
13 | chr6:5569800-5570200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr6:5569800-5571200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |